Detroit, Michigan
Colorectal cancer clinical trials in Detroit, MI
35 colorectal cancer studies are recruiting participants at sites in Detroit as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Detroit at a glance
- 35 studies are recruiting at a site in Detroit.
- By phase: Phase 1 (12), Phase 1/2 (5), Phase 2 (4), Phase 2/3 (1), Phase 3 (6), No phase (6), Observational (1). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (23), university, hospital or other (11), government (1).
- Most recent update to one of these records: November 16, 2026.
Studies recruiting in Detroit
Basic details from each study's public record (the 30 most recently updated of 35). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- GlaxoSmithKline
- Study site
- GSK Investigational Site
- Registry record
- NCT07213609 · updated
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- Barbara Ann Karmanos Cancer Center
- Registry record
- NCT07488676 · updated
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Study site
- Karmanos Cancer Institute
- Registry record
- NCT07503808 · updated
The Vanguard Study: Testing a New Way to Screen for Cancer
- No phase
- Ages 45 to 75
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Henry Ford Hospital · Henry Ford Medical Center - Detroit Northwest
- Registry record
- NCT06995898 · updated
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- SWOG Cancer Research Network
- Study site
- Henry Ford Health Saint John Hospital
- Registry record
- NCT07018869 · updated
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Summit Therapeutics
- Registry record
- NCT07228832 · updated
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Oncolytics Biotech
- Study site
- Karmanos Cancer Institute
- Registry record
- NCT07446322 · updated
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- NRG Oncology
- Study site
- Henry Ford Health Saint John Hospital
- Registry record
- NCT05174169 · updated
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Observational
- Ages 40 to 75
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Henry Ford Health Saint John Hospital · Henry Ford Hospital
- Registry record
- NCT05334069 · updated
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Barbara Ann Karmanos Cancer Institute
- Registry record
- NCT07114601 · updated
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Barbara Ann Karmanos Cancer Institute
- Registry record
- NCT07213791 · updated
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Henry Ford Health Saint John Hospital
- Registry record
- NCT07283939 · updated
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Henry Ford Hospital
- Registry record
- NCT05673148 · updated
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Sairopa B.V.
- Study site
- Henry Ford Cancer Institute
- Registry record
- NCT05856981 · updated
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Henry Ford Hospital
- Registry record
- NCT06662786 · updated
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Henry Ford Hospital
- Registry record
- NCT06750094 · updated
Family Communications After Genetic Testing
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Henry Ford Health Saint John Hospital
- Registry record
- NCT07143487 · updated
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kumquat Biosciences Inc.
- Study site
- Karmanos Cancer Institute
- Registry record
- NCT07542704 · updated
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BioNTech SE
- Study site
- Karmanos Cancer Institute
- Registry record
- NCT07186842 · updated
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kura Oncology, Inc.
- Study site
- Henry Ford Health System
- Registry record
- NCT06026410 · updated
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
- No phase
- Ages 65 to 82
- All sexes
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Study site
- Henry Ford
- Registry record
- NCT05612347 · updated
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Exelixis
- Study sites
- Exelixis Clinical Site #13 · Exelixis Clinical Site #65
- Registry record
- NCT05176483 · updated
A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Iambic Therapeutics, Inc
- Study site
- Henry Ford Cancer Institute
- Registry record
- NCT06253871 · updated
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Marengo Therapeutics, Inc.
- Study site
- Karmanos Cancer Institute
- Registry record
- NCT05592626 · updated
A Study of ASP1002 in Adults for Treatment of Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- Henry Ford Hospital
- Registry record
- NCT05719558 · updated
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- MOMA Therapeutics
- Registry record
- NCT06974110 · updated
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Coherus Oncology, Inc.
- Study site
- Henry Ford Health System
- Registry record
- NCT06657144 · updated
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Endevica Bio
- Study site
- Karmanos Cancer Center
- Registry record
- NCT06937177 · updated
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Canadian Cancer Trials Group
- Study site
- Henry Ford Hospital
- Registry record
- NCT06205485 · updated
Efficacy and Safety of the CG-100 Intraluminal Bypass Device
- No phase
- Ages 22 to 70
- All sexes
- Sponsor
- Colospan Ltd.
- Study site
- Henry Ford Health System
- Registry record
- NCT04184973 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Detroit, MI on ClinicalTrials.gov.
Ask about studies near Detroit
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Michigan
All Michigan locations
91 studies recruiting across 58 cities.
Grand Rapids
50 studies recruiting.
Ann Arbor
29 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections